Merck agrees to settle Missouri Vioxx lawsuit

Friday, November 2, 2012 | 10:07 a.m. CDT; updated 11:05 a.m. CDT, Friday, November 2, 2012

ST. LOUIS — Drugmaker Merck & Co. Inc. has reached a settlement in a class action lawsuit filed on behalf of Missouri consumers who used the prescription pain reliever Vioxx for treatment of arthritis conditions.

The settlement was over claims that New Jersey-based Merck violated the Missouri Merchandising Practices Act through the promotion and sale of Vioxx. The agreement must still be approved by Jackson County Circuit Court.

Vioxx was removed from the market in 2004 after evidence showed it doubled the risk of heart attack and stroke.

The settlement requires Merck to pay all validated claims submitted by Missouri Vioxx users, along with attorneys' fees and other costs. All told, Merck could pay up to $220 million, according to the agreement.

Merck admitted no wrongdoing in the settlement.

Like what you see here? Become a member.

Show Me the Errors (What's this?)

Report corrections or additions here. Leave comments below here.

You must be logged in to participate in the Show Me the Errors contest.


Leave a comment

Speak up and join the conversation! Make sure to follow the guidelines outlined below and register with our site. You must be logged in to comment. (Our full comment policy is here.)

  • Don't use obscene, profane or vulgar language.
  • Don't use language that makes personal attacks on fellow commenters or discriminates based on race, religion, gender or ethnicity.
  • Use your real first and last name when registering on the website. It will be published with every comment. (Read why we ask for that here.)
  • Don’t solicit or promote businesses.

We are not able to monitor every comment that comes through. If you see something objectionable, please click the "Report comment" link.

You must be logged in to comment.

Forget your password?

Don't have an account? Register here.